Circular No. 33/2023/TT-BYT stipulates the list of Group B infectious diseases prioritized for budget allocation for medical examination and treatment activities. The diseases include: Rabies; Tuberculosis; Tetanus; HIV/AIDS; Malaria; Streptococcus suis in humans; Anthrax; Viral Encephalitis. This Circular takes effect from January 1, 2024.
적용 범위
Ministry of Health, relevant agencies, organizations, individuals in the health sector, and units under the Ministry of Health.
핵심 사항
- Group B infectious diseases including: Rabies; Tuberculosis; Tetanus; HIV/AIDS; Malaria; Streptococcus suis in humans; Anthrax; Viral Encephalitis → are prioritized for budget allocation for medical examination and treatment activities.
- This Circular takes effect from January 1, 2024.
🌐 이 문서의 사회적 영향
- Positive impact: Helps improve the quality of community healthcare services, reduce the risk of spreading Group B infectious diseases.
- Negative impact: May increase costs for the state budget in the initial period.
❓ 자주 묻는 질문
Which diseases are prioritized for budget allocation?
Group B infectious diseases include: Rabies; Tuberculosis; Tetanus; HIV/AIDS; Malaria; Streptococcus suis in humans; Anthrax; Viral Encephalitis.
When does this Circular take effect?
This Circular takes effect from January 1, 2024.
Who is responsible for implementing this Circular?
Director of the Ministry's Office, Director of the Preventive Medicine Department, Director of the Medical Examination and Treatment Management Department, Inspector General of the Ministry; Heads of Departments and Directors of Units under the Ministry of Health and relevant agencies, organizations, and individuals.
Are Group B infectious diseases prioritized for budget allocation for medical examination and treatment activities?
Yes, this Circular stipulates the list of Group B infectious diseases prioritized for budget allocation for medical examination and treatment activities.
To whom does this Circular apply?
This Circular applies to the Ministry of Health, relevant agencies, organizations, individuals in the health sector, and units under the Ministry of Health.
전문
|
MINISTRY OF HEALTH |
SOCIALIST REPUBLIC OF VIET NAM |
|
NUMBER: 33/2023/TT-BYT |
HA NOI, December 31, 2023 |
CIRCULAR
REGULATIONS ON THE LIST OF GROUP B INFECTIOUS DISEASES TO BE PRIORITIZED FOR BUDGET ALLOCATION FOR MEDICAL EXAMINATION AND TREATMENT ACTIVITIES
Pursuant to the Law on Medical Examination and Treatment No. 15/2023/QH15 dated January 9, 2023,
Pursuant to Decree No. 95/2022/NĐ-CP dated November 15, 2022 of the Government stipulating the functions, tasks, powers, and organizational structure of the Ministry of Health;
At the proposal of the Director of the Preventive Health Department;
The Minister of Health issues this Circular to regulate the List of Group B infectious diseases to be prioritized for budget allocation for medical examination and treatment activities.
Article 1. The List of Group B infectious diseases to be prioritized for budget allocation for medical examination and treatment activities includes the following diseases: Rabies; Tuberculosis; Tetanus; HIV/AIDS; Malaria; Human Swine Erysipelas; Anthrax; Viral Encephalitis.
Article 2. This Circular takes effect from January 1, 2024.
Article 3. The Director of the Ministry's Office, the Director of the Preventive Medicine Department, the Director of the Medical Examination and Treatment Management Department, the Inspector General of the Ministry; Heads of Departments and Directors of all Departments and Units under the Ministry of Health and related organizations, individuals are responsible for implementing this Circular.
|
Place of Receipt: |
DEPUTY MINISTER |
원본 문서(PDF)
관계도
문서를 클릭하면 열립니다. 빨간 테두리＝효력을 변경하는 관계.
번역본
이 문서는 다음 언어로 제공됩니다: